Examiner: NOAKES, SUZANNE MARIE

Tech Center 1700 • Art Units: 1656 1683 1759

This examiner grants 73% of resolved cases

Performance Statistics

73.3%

Allow Rate

+8.3% vs TC avg

1,106

Total Applications

+18.1%

Interview Lift

943

Avg Prosecution Days

Based on 1069 resolved cases, 2023–2026

6.4%

§101 Eligibility

23.0%

§102 Novelty

24.6%

§103 Obviousness

30.0%

§112 Clarity

App #	Title	Status	Assignee
17781873	CHO CELL-DERIVED PROTEIN SECRETORY FACTORS AND EXPRESSION VECTORS COMPRISING THE SAME	Non-Final OA	LG CHEM, LTD
18795872	Streptococcus Canis Cas9 as a Genome Engineering Platform with Novel PAM Specificity	Non-Final OA	Massachusetts Institute of Technology
18764634	RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci	Final Rejection	The General Hospital Corporation

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.